Search results
AstraZeneca's (AZN) Dato-DXd Meets Goal in Breast Cancer Study
Zacks via Yahoo Finance· 9 months agoAstraZeneca (AZN) announces positive results from the late-stage study evaluating its antibody-drug...
AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance
Zacks via Yahoo Finance· 2 months agoAstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has accepted their biologics...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 2 weeks agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
This playful cat food packaging is the cutest thing you'll see today
Creative Bloq via Yahoo News· 8 months agoMaowoo cat food packaging . Cat food brand Maowoo has teamed up with design agency DXD to create a...
Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
Zacks via Yahoo Finance· 5 months agoMerck (MRK) and Daiichi Sankyo's regulatory filing for HER3-DXd gets the FDA's priority review grant...
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) reported initial results from the TROPION-Lung02 phase 1b trial...
Enhertu for Breast Cancer: Benefits, Side Effects, and Cost
Verywell Health via Yahoo News· 2 years agoFam-trastuzumab deruxtecan-nxki, trastuzumab deruxtecan, or T-DXd skaman306 / Getty Images Medically...
HER2-Low Breast Cancer Treatment
Verywell Health via Yahoo News· 11 months agoPrecision Therapy for a Hard-to-Treat Cancer Daniel Llao Calvet / Getty Images Medically reviewed by Benjamin Leach, MD For those with breast cancer,...
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) reported initial data from the TROPION-PanTumor01 Phase 1 trial of...
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via Yahoo Finance· 2 weeks agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...